Literature DB >> 29205833

Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses.

Peng Zhou1,2,3, Teng Guan2, Zhao Jiang2,4, Mike Namaka4,5, Qing-Jun Huang4, Ji-Ming Kong1,2,4.   

Abstract

AIMS: Oligodendrocytes, especially oligodendrocyte precursor cells, are known to be sensitive to hypoxic and metabolic stresses. Vulnerability of oligodendrocytes is considered a contributing factor to white matter dysfunction. However, little is known about the energy processing characteristics of oligodendrocyte lineage cells under basal and metabolic stress conditions. The aim of this study was to identify the energy requirements and cellular responses of oligodendrocytes at different developmental stages.
METHODS: We compared the metabolic stress responses between myelinating oligodendrocytes (OLs) and oligodendrocyte precursor cells (OPCs). Differential regulation of cellular response was also investigated.
RESULTS: We found that, following cerebral ischemia, monocarboxylate transporter 1 (MCT1) expression was upregulated in the peri-infarct striatum but not in the cortex of the brain. In vitro ischemia models were used to induce oligodendrocyte stress as well. An increase in MCT1 expression was detected in OPCs after a mild oxygen-glucose deprivation. Double-labeled immunohistochemical analysis revealed that OPCs and OLs responded differently to metabolic stresses and that the susceptibility to metabolic stresses of OPCs and OLs was associated with their distinct expression profiles of MCT1.
CONCLUSION: Taken together, this study shows that MCT1 plays a role in the responses of OPCs and OLs to metabolic and ischemic stresses and suggests that redistribution of energy substrates is a determinant in white matter injury.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  metabolic stress; monocarboxylate transporter 1; oligodendrocyte

Mesh:

Substances:

Year:  2017        PMID: 29205833      PMCID: PMC6489895          DOI: 10.1111/cns.12782

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  18 in total

1.  Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep.

Authors:  Jiming Kong; P Nicolas Shepel; Clark P Holden; Mirek Mackiewicz; Allan I Pack; Jonathan D Geiger
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 2.  Assembly of a new growth cone after axotomy: the precursor to axon regeneration.

Authors:  Frank Bradke; James W Fawcett; Micha E Spira
Journal:  Nat Rev Neurosci       Date:  2012-02-15       Impact factor: 34.870

Review 3.  Oligodendroglia: metabolic supporters of axons.

Authors:  Brett M Morrison; Youngjin Lee; Jeffrey D Rothstein
Journal:  Trends Cell Biol       Date:  2013-08-27       Impact factor: 20.808

4.  Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments.

Authors:  Tiina Sairanen; Marja-Liisa Karjalainen-Lindsberg; Anders Paetau; Petra Ijäs; Perttu J Lindsberg
Journal:  Brain       Date:  2005-11-04       Impact factor: 13.501

5.  Monocarboxylic acid transporters, MCT1 and MCT2, in cortical astrocytes in vitro and in vivo.

Authors:  R Hanu; M McKenna; A O'Neill; W G Resneck; R J Bloch
Journal:  Am J Physiol Cell Physiol       Date:  2000-05       Impact factor: 4.249

Review 6.  Regulation of conduction time along axons.

Authors:  A H Seidl
Journal:  Neuroscience       Date:  2013-06-29       Impact factor: 3.590

7.  Regulation of oligodendrocyte development and myelination by glucose and lactate.

Authors:  Johanne E Rinholm; Nicola B Hamilton; Nicoletta Kessaris; William D Richardson; Linda H Bergersen; David Attwell
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

8.  BNIP3 mediates pre-myelinating oligodendrocyte cell death in hypoxia and ischemia.

Authors:  Chengren Li; Teng Guan; Xueping Chen; Wenyan Li; Qiyan Cai; Jianqin Niu; Lan Xiao; Jiming Kong
Journal:  J Neurochem       Date:  2013-06-05       Impact factor: 5.372

9.  Oligodendroglia metabolically support axons and contribute to neurodegeneration.

Authors:  Youngjin Lee; Brett M Morrison; Yun Li; Sylvain Lengacher; Mohamed H Farah; Paul N Hoffman; Yiting Liu; Akivaga Tsingalia; Lin Jin; Ping-Wu Zhang; Luc Pellerin; Pierre J Magistretti; Jeffrey D Rothstein
Journal:  Nature       Date:  2012-07-26       Impact factor: 49.962

10.  Lactate-starved neurons in ALS.

Authors:  Bryan A Martinez
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more
  9 in total

1.  Oligodendrocyte Bioenergetics in Health and Disease.

Authors:  Lauren Rosko; Victoria N Smith; Reiji Yamazaki; Jeffrey K Huang
Journal:  Neuroscientist       Date:  2018-08-20       Impact factor: 7.519

Review 2.  Impaired Oligodendrocyte Development Following Preterm Birth: Promoting GABAergic Action to Improve Outcomes.

Authors:  Julia C Shaw; Gabrielle K Crombie; Hannah K Palliser; Jonathan J Hirst
Journal:  Front Pediatr       Date:  2021-02-04       Impact factor: 3.418

3.  Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients.

Authors:  Yan Chen; Zheng Zheng; Ainong Mei; Huan Huang; Fan Lin
Journal:  Clinics (Sao Paulo)       Date:  2021-05-17       Impact factor: 2.365

Review 4.  Monocarboxylate Transporter 1 May Benefit Cerebral Ischemia via Facilitating Lactate Transport From Glial Cells to Neurons.

Authors:  Mao Zhang; Yanyan Wang; Yun Bai; Limeng Dai; Hong Guo
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003

Review 5.  Mitochondria in Myelinating Oligodendrocytes: Slow and Out of Breath?

Authors:  Niklas Meyer; Johanne Egge Rinholm
Journal:  Metabolites       Date:  2021-06-05

Review 6.  Glucose metabolic crosstalk and regulation in brain function and diseases.

Authors:  Shuai Zhang; Brittany Bolduc Lachance; Mark P Mattson; Xiaofeng Jia
Journal:  Prog Neurobiol       Date:  2021-06-10       Impact factor: 10.885

7.  Hypoxic preconditioning improves long-term functional outcomes after neonatal hypoxia-ischemic injury by restoring white matter integrity and brain development.

Authors:  Ming-Yue Xu; Yang-Fan Wang; Peng-Ju Wei; Yan-Qin Gao; Wen-Ting Zhang
Journal:  CNS Neurosci Ther       Date:  2019-01-28       Impact factor: 5.243

Review 8.  Oligodendroglial Energy Metabolism and (re)Myelination.

Authors:  Vanja Tepavčević
Journal:  Life (Basel)       Date:  2021-03-13

Review 9.  Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy.

Authors:  Di Chen; Yichen Huang; Ziyu Shi; Jiaying Li; Yue Zhang; Ke Wang; Amanda D Smith; Ye Gong; Yanqin Gao
Journal:  CNS Neurosci Ther       Date:  2020-11-19       Impact factor: 5.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.